Jia and colleagues have unveiled a significant finding regarding AKI, demonstrating that targeted ablation of the chemokine CCL2 specifically within the proximal renal tubules can mitigate kidney damage by reducing macrophage infiltration and the expression of pro-inflammatory cytokines. The gene discussed is CCL2; the disease is acute kidney injury.